EL

What Our Analysts Know About Estée Lauder

Now trading at a price of $99.18, Estée Lauder has moved 2.4% so far today.

Estée Lauder returned losses of -44.0% last year, with its stock price reaching a high of $183.2 and a low of $95.87. Over the same period, the stock underperformed the S&P 500 index by -64.8%. AThe company's 50-day average price was $116.12. The Estée Lauder Companies Inc. manufactures, markets, and sells skin care, makeup, fragrance, and hair care products worldwide. Based in New York, NY, the Large-Cap Consumer Discretionary company has 44,020 full time employees. Estée Lauder has offered a 2.7% dividend yield over the last 12 months.

Wider Gross Margins Than the Industry Average of 58.31%:

2018 2019 2020 2021 2022 2023
Revenue (M) $13,683 $14,863 $14,294 $16,215 $17,737 $15,910
Gross Margins 79% 77% 75% 76% 76% 71%
Net Margins 8% 12% 5% 18% 14% 6%
Net Income (M) $1,117 $1,794 $684 $2,875 $2,408 $1,010
Net Interest Expense (M) $128 $133 $161 $173 $167 $255
Depreciation & Amort. (M) $531 $557 $611 $651 $727 $744
Diluted Shares (M) 370 367 368 366 360 360
Earnings Per Share $3.02 $4.89 $1.86 $7.86 $6.68 $2.81
EPS Growth n/a 61.92% -61.96% 322.58% -15.01% -57.93%
Avg. Price $134.07 $170.18 $199.35 $305.28 $272.63 $99.18
P/E Ratio 44.1 34.24 104.92 38.35 40.39 35.17
Free Cash Flow (M) $1,933 $1,773 $1,657 $2,994 $2,000 $728
CAPEX (M) $629 $744 $623 $637 $1,040 $1,003
EV / EBITDA 19.5 21.94 59.59 33.95 25.39 17.39
Total Debt (M) $3,391 $5,178 $6,135 $5,291 $5,379 $7,637
Net Debt / EBITDA 0.47 0.55 0.48 0.21 0.42 1.64
Current Ratio 1.71 1.69 1.9 1.73 1.66 1.36

Estée Lauder has slight revenue growth and increasing reinvestment in the business, wider gross margins than its peer group, and healthy leverage levels. However, the firm has positive cash flows. Finally, we note that Estée Lauder has flat EPS growth and just enough current assets to cover current liabilities, as shown by its current ratio of 1.36.

Estée Lauder's Valuation Is in Line With Its Sector Averages:

Estée Lauder has a trailing twelve month P/E ratio of 65.2, compared to an average of 22.15 for the Consumer Discretionary sector. Based on its EPS guidance of $4.05, the company has a forward P/E ratio of 28.7. The 4.3% compound average growth rate of Estée Lauder's historical and projected earnings per share yields a PEG ratio of 15.24. This suggests that these shares are overvalued. Furthermore, Estée Lauder is likely overvalued compared to the book value of its equity, since its P/B ratio of 6.19 is higher than the sector average of 3.11. The company's shares are currently trading 213.2% below their Graham number. Ultimately, Estée Lauder's strong cash flows, decent earnings multiple, and healthy debt levels factor towards it being fairly valued, its elevated P/B ratio notwithstanding.

Estée Lauder Has an Average Rating of Hold:

The 25 analysts following Estée Lauder have set target prices ranging from $108.0 to $191.0 per share, for an average of $137.82 with a hold rating. The company is trading -28.0% away from its average target price, indicating that there is an analyst consensus of strong upside potential.

Estée Lauder has an average amount of shares sold short because 2.7% of the company's shares are sold short. Institutions own 91.8% of the company's shares, and the insider ownership rate stands at 0.39%, suggesting a small amount of insider investors. The largest shareholder is Vanguard Group Inc, whose 9% stake in the company is worth $2,051,692,035.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS